*Program and presenters subject to change. Please check back frequently for updates.
Presenter: Karl-Heinz Huemer, MD, PhD (he/him/his) – khhconsulting
### he/him/his @@@ Linda McBride, R.PH, RAC – IAA Consulting LLC ### 1946958###Presenter###Partner###IAA Consulting LLC###Presenter: Linda McBride, R.PH, RAC – IAA Consulting LLC
### @@@ Kimberly Belsky, MS, FRAPS (she/her/hers) – Planning Committee Chair Convergence 2023 ### 535468###Presenter###Global Reg Policy & Intelligence and AdPromo###Planning Committee Chair Convergence 2023###Presenter: Kimberly Belsky, MS, FRAPS (she/her/hers) – Planning Committee Chair Convergence 2023
### she/her/hersKeynote Speaker: Janice Chang – TransCelerate BioPharma Inc.
### @@@ Ginny Beakes-Read, JD – Janssen Pharmaceuticals ### 2122616###Panelist###VP, Global Regulatory Policy and Intelligence###Janssen Pharmaceuticals###Panelist: Ginny Beakes-Read, JD – Janssen Pharmaceuticals
### @@@ Sabine Haubenreisser, MSc, PhD – European Medicines Agency ### 844384###Panelist###Principal Scientific Administrator###European Medicines Agency###Panelist: Sabine Haubenreisser, MSc, PhD – European Medicines Agency
### @@@ Christine Mayer-Nicolai, PhD (she/her/hers) – Merck KGaA, Darmstadt, Germany ### 2123255###Panelist###VP; Global Head Regulatory & Scientific Policy###Merck KGaA, Darmstadt, Germany###Panelist: Christine Mayer-Nicolai, PhD (she/her/hers) – Merck KGaA, Darmstadt, Germany
### she/her/hers @@@ Janet Woodcock, MD – United States Food and Drug Administration ### 596742###Panelist###Principal Deputy Commissioner###United States Food and Drug Administration###Panelist: Janet Woodcock, MD – United States Food and Drug Administration
###Moderator: Jethro E. Ekuta – Alexion, AstraZeneca Rare Disease
### @@@ Florence Butlen – European Medicines Agency ### 2134569###Panelist######European Medicines Agency###Panelist: Florence Butlen – European Medicines Agency
### @@@ Aman Khera, EMBA, FRAPS, FTOPRA (she/her/hers) – Worldwide Clinical Trials ### 593742###Panelist###Vice President, Regulatory Science, Strategy & Innovation###Worldwide Clinical Trials###Panelist: Aman Khera, EMBA, FRAPS, FTOPRA (she/her/hers) – Worldwide Clinical Trials
### she/her/hersSession Leader: Nancy J. Morrison, RAC (she/her/hers) – RQM+
### she/her/hers @@@ Hrishikesh Gadagkar, PhD (he/him/his) – RQM Plus ### 1977462###Presenter###Sr. Principal###RQM Plus###Presenter: Hrishikesh Gadagkar, PhD (he/him/his) – RQM Plus
### he/him/hisWorkshop Leader: Bassil Akra, phD (he/him/his) – Akra Team GmbH
### he/him/his @@@ Danielle Giroud, MSci (she/her/hers) – MD-CLINICALS SA ### 1187621###Presenter###CEO###MD-CLINICALS SA###Presenter: Danielle Giroud, MSci (she/her/hers) – MD-CLINICALS SA
### she/her/hers @@@ Keith Morel, PhD (he/him/his) – Qserve Group ### 535522###Presenter###VP Regulatory Compliance###Qserve Group###Presenter: Keith Morel, PhD (he/him/his) – Qserve Group
### he/him/his @@@ Alexey Shiryaev, MD PhD – DNV Product Assurance AS ### 1645653###Presenter###Global Head of Clinical and Regulatory Affairs###DNV Product Assurance AS###Presenter: Alexey Shiryaev, MD PhD – DNV Product Assurance AS
### @@@ Erik R. Vollebregt – Axon Lawyers ### 535481###Presenter###Partner###Axon Lawyers###Presenter: Erik R. Vollebregt – Axon Lawyers
###
